Salta al contenuto principale
Passa alla visualizzazione normale.

MARIO BARBAGALLO

Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: Results from the REPOSI registry

  • Autori: Pasina, L; Brucato, AL; Djade, CD; Di Corato, P; Ghidoni, S; Tettamanti, M; Franchi, C; Salerno, F; Corrao, S; Marengoni, A; Marcucci, M; Mannucci, PM; Nobili, A; REPOSI, Investigators; Barbagallo, M; Dominguez Rodriguez, LJ
  • Anno di pubblicazione: 2014
  • Tipologia: Articolo in rivista (Articolo in rivista)
  • OA Link: http://hdl.handle.net/10447/104666

Abstract

Purpose: To investigate the prevalence of xanthine oxidase (XO) inhibitors prescription at admission and discharge in elderly hospital in-patients, to analyze the appropriateness of their use in relation to evidence-based indications, to evaluate the predictors of inappropriate prescription at discharge and the association with adverse events 3 months after hospital discharge. Methods: This cross-sectional study, based upon a prospective registry, was held in 95 Italian internal medicine and geriatric hospital wards. The sample included 4035 patients aged 65 years or older at admission and 3502 at discharge. The prescription of XO inhibitors was considered appropriate in patients with diagnosis of gout, gout nephropathy, uric acid nephrolithiasis, tophi, and chemotherapy-induced hyperuricemia. In order to evaluate the predictors of inappropriate prescription of XO inhibitors, we compared the characteristics of patients considered inappropriately treated with those appropriately not tre...